Endpoints News Mar 28, 2026 #AAD26: Tanabe’s Phase 3 win for drug targeting rare diseases that cause pain upon light exposure
Endpoints News Mar 28, 2026 A week of bolt-on deals; Wave crashes on obesity data; Sanofi partners with TCE startup; and more
Endpoints News Mar 27, 2026 CHMP recommends subcutaneous form of Sanofi's Sarclisa and four new drugs
Endpoints News Mar 27, 2026 AnaptysBio spins out biotech operations; Affibody's data in hidradenitis suppurativa
Endpoints News Mar 27, 2026 AstraZeneca’s in vivo CAR-T led to early responses, but one death in China trial
Endpoints News Mar 27, 2026 Novartis to spend up to $2B on Excellergy and its next-gen Xolair candidate
Endpoints News Mar 27, 2026 AstraZeneca’s COPD antibody gets Phase 3 wins in broader-than-expected population
Endpoints News Mar 26, 2026 Biopharma industry pushes back on FDA's 'America First' user fee proposals